ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 95 filers reported holding ALBIREO PHARMA INC in Q3 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $400,000 | +28.2% | 13,394 | 0.0% | 0.01% | 0.0% |
Q4 2021 | $312,000 | -39.1% | 13,394 | -18.4% | 0.01% | -11.1% |
Q3 2021 | $512,000 | -27.9% | 16,408 | -18.7% | 0.01% | -30.8% |
Q2 2021 | $710,000 | -21.0% | 20,188 | -20.8% | 0.01% | -13.3% |
Q1 2021 | $899,000 | +4.2% | 25,500 | +10.9% | 0.02% | -6.2% |
Q4 2020 | $863,000 | +23.8% | 23,001 | +10.1% | 0.02% | -23.8% |
Q3 2020 | $697,000 | – | 20,900 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 480,000 | $14,318,000 | 9.25% |
Decheng Capital Management III (Cayman), LLC | 518,342 | $15,462,000 | 4.74% |
TANG CAPITAL MANAGEMENT LLC | 467,702 | $13,952,000 | 2.79% |
Birchview Capital, LP | 113,000 | $3,371,000 | 2.43% |
Privium Fund Management B.V. | 351,805 | $10,494,000 | 2.32% |
Sio Capital Management, LLC | 144,546 | $4,312,000 | 1.43% |
Perceptive Advisors | 2,360,139 | $70,403,000 | 1.41% |
Chicago Capital, LLC | 1,011,744 | $30,180,000 | 1.30% |
Endurant Capital Management LP | 120,834 | $3,604,000 | 0.95% |
Nicholas Investment Partners, LP | 439,235 | $13,102,000 | 0.93% |